Intra-Cellular Therapies
ITCI
#1565
Rank
โ‚น1.273 T
Marketcap
โ‚น11,953
Share price
0.00%
Change (1 day)
99.65%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Last known market cap: โ‚น1.273 Trillion

On May 30, 2025 Intra-Cellular Therapies had a market cap of โ‚น1.273 Trillion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.260 T63.41%
2024โ‚น771.69 B34.49%
2023โ‚น573.79 B38.36%
2022โ‚น414.72 B30.68%
2021โ‚น317.35 B69.59%
2020โ‚น187.12 B37.79%
2019โ‚น135.80 B210.64%
2018โ‚น43.71 B-13.36%
2017โ‚น50.46 B13.73%
2016โ‚น44.36 B-71.24%
2015โ‚น154.26 B367.5%
2014โ‚น32.99 B20.52%
2013โ‚น27.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
โ‚น76.82 B-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
โ‚น7.32 B-99.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚น1.18 B-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA